Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Two siblings both had a rare case of alopecia areata at the same time.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Thyroid disease can cause skin and hair changes, treatable with levothyroxine.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Hair loss in children with alopecia areata is more common in winter and linked to climate factors like air pressure and sunlight.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Selenium can be toxic to animals, causing serious health issues, especially in horses.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

The editor suggests removing "race" and "ethnicity" from dermatology and creating tools to objectively assess skin color and hair texture.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

People with alopecia who are more resilient tend to feel less stressed.

Cannabis might help hair regrowth in alopecia areata.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

DNA methylation is essential for skin and hair follicle development, and could be a target for treating skin diseases.